Participated · Equity · Jul 2026

TytoCare develops a clinician-grade handheld remote examination platform paired with FDA-cleared AI-powered software-as-a-medical-device algorithms to enable comprehensive remote physical exams. The company serves health systems, payers, and employer health programs and is positioning its platform for cardiopulmonary screening, oncology supportive care, and chronic disease management including CHF and COPD. TytoCare announced leadership appointments of Adam Pellegrini as CEO and Greg Orr as COO concurrent with its $25M+ growth round led by Insight Partners. The company intends to use the new capital to expand its AI algorithm pipeline, deepen integrations with health systems and payers, and accelerate go-to-market efforts. TytoCare is headquartered in New York and Netanya, Israel, and emphasizes FDA-cleared diagnostic fidelity as a competitive differentiator.

Participated · Seed · Feb 2026

SpendRule has built what it calls healthcare’s first AI-driven contract intelligence platform focused on the largely unmanaged purchased-services category, which represents nearly half of a health system’s non-labor spend. The software converts complex contract provisions into executable logic and embeds them into existing accounts-payable workflows, enabling real-time, four-way matching of purchase orders, receipts, invoices and contract terms. When discrepancies arise, the system flags them with supporting evidence before payment is issued, preventing leakage that industry observers estimate exceeds $32 billion annually. Health systems such as OSF HealthCare, Kettering Health, MemorialCare and MUSC Health are already using the product to shift from reactive audits to proactive invoice prevention, freeing staff from thousands of hours of manual review. Because the platform layers on top of a hospital’s existing ERP or AP system, adoption requires no rip-and-replace effort. SpendRule’s vision is to give supply-chain teams continuous visibility and automated enforcement across thousands of lengthy service contracts, ensuring negotiated savings reach the bottom line. The company is backed by healthcare-focused investors and is leveraging the commercial acceleration capabilities of health-system partners in the Abundant Alliance.

Participated · Series B · May 2025

Carta Healthcare provides an AI-powered platform that automates clinical data abstraction and analytics, combining machine learning with deep clinical expertise to extract and structure both structured and unstructured clinical data. Its technology generates actionable insights for health systems and life sciences organizations, streamlining data abstraction processes and reducing labor costs. The company plans to expand its customer footprint—particularly in the life sciences market—and to scale product deployment and operations following its late-2024 acquisition of Realyze Intelligence from UPMC Enterprises. The Realyze Intelligence acquisition added capabilities for rapidly analyzing data and identifying patients who match clinical trials and research studies. Founded in 2017 and headquartered in San Francisco, Carta reports consistent year-over-year growth and says the new capital will support hiring, infrastructure, and expanded market demand. The company’s CFO described Carta as financially healthy and positioned to strengthen its balance sheet and capture market opportunity. Carta Healthcare delivers collection, analysis, and insights into clinical data by providing registry data abstraction, reporting, and analytics to leading health systems. The company combines state-of-the-art technology with a team of experienced clinicians to produce high-quality registry data and associated analytics. By transforming the abstraction process and implementing powerful analytic capabilities, Carta informs data-driven decisions that can improve patient outcomes, reduce data-processing costs, and enable clinicians to spend more time on patient care. The company reports markedly faster data collection, superior data quality, and considerable cost savings for healthcare providers. Carta intends to use the recent funding to scale operations and accelerate product development to make more products accessible to more health systems. The business is focused on enhancing healthcare data processes and analytics to support better patient outcomes and research capabilities. Carta Healthcare provides AI-driven clinical data abstraction technology and services that use natural language processing and machine learning to reduce manual labor in curating trustworthy, actionable datasets. Its platform collects, analyzes, and layers analytic capabilities on clinical data to fuel data-driven healthcare decisions and improve patient care. The company supports the healthcare data registry market by transforming previously manual abstraction processes into automated workflows. Carta plans to use new funding to expand its clinical and technical teams and build new partnerships to make healthcare data more actionable. The company emphasizes making data-driven improvements to care delivery and bringing its solutions to new partners. Carta was founded in 2017 and is headquartered in San Francisco; it announced a recent Series A to accelerate growth.

Participated · Equity · Sep 2024

Centivo builds employer-focused, primary care-centered health plans that combine an in-house virtual primary care practice (Centivo Care), direct contracts with accountable care organizations (ACOs) in 18 major markets, and a tech-enabled member engagement and plan administration platform. The company says its model can lower total cost of care by 30% or more, typically saves employers 15% or more, and increased utilization of primary and specialty care. In 2023 Centivo’s health plans achieved a 71% reduction in member out-of-pocket costs compared to the plans they replaced, and the company says its approach reduces annual employee out-of-pocket costs by nearly $1,200. Following Centivo’s acquisition of virtual-first medical provider Eden Health in May, the company expanded its PCMH-certified virtual primary care capabilities and integrated behavioral health into its platform. Centivo serves Americans in all 50 states across a diverse set of industries and plans to use recent capital to enhance and scale its product and technology and forge new strategic partnerships with health systems. Its stated mission is to bring affordable, high-quality healthcare to working families by curbing inefficiency and waste in employer-sponsored plans. Centivo offers health plans for self-insured employers anchored around relationships with accountable care providers and a primary-care-centered clinical model. Its plan designs include free adult and pediatric primary care for all visits, no deductibles, predictable copays for non-primary care, and integrated virtual primary care. Centivo says employers typically save 15–30% annually versus traditional insurance and that members’ medical and pharmacy out-of-pocket costs average under $350 per person per year. The company reports primary care utilization has increased by more than 30% while quality and member satisfaction have strengthened. Centivo serves employers ranging from 51 employees to Fortune 500 companies and has a market presence in 13 states. The company launched in 2019 and is pursuing rapid growth and expansion amid increased employer demand. Centivo is a Buffalo, NY-based health plan company led by CEO Ashok Subramanian. Its core product is a health plan anchored around providers of value-based care for self-funded employers. The company serves employer clients ranging in size from 100 employees to Fortune 500 companies. It recently launched a fully integrated virtual primary care-centered health plan in Florida. Centivo plans to use new funding for growth, expansion and development of products and services, including its virtual primary care-centered plan. By the end of 2022 the company’s health plan will be available in half of the top 20 metropolitan areas in the country, and it has a new strategic distribution arrangement with the Business Health Care Group in eastern Wisconsin. Centivo provides a benefits solution built for self-funded employers, offering affordable and predictable costs, a technology-driven member experience, and a range of benefit options including traditional and proprietary networks. The company develops high-value networks in partnership with local healthcare providers and uses data analytics to refine networks and direct members to appropriate providers. Members receive a primary care–centered model with expanded access and fully integrated virtual care. Provider partners include health systems such as Mount Sinai Health System, Orlando Health, Scripps Health, and UCLA Health, as well as independent practices. Centivo’s solution is available to mid-sized and large employers in New York, New Jersey, Connecticut, Southern California, Florida, and North Carolina, with plans to expand to additional markets in 2021. The company is led by CEO and co-founder Ashok Subramanian and has offices in Stamford, CT; Buffalo, NY; and New York, NY. Centivo is a New York City–based, new type of self-funded health plan built specifically for employers and their employees and families. Led by CEO and co-founder Ashok Subramanian, the company serves as a health plan or third-party administrator and partners closely with local health plans and TPAs to enhance offerings. Its model centers on an innovative primary care–centered network focused on outcomes, a dynamic benefit design that rewards members for high-value care and adherence, and a digital technology platform and concierge support to improve care and experience. Centivo is launching its product for the 2019 plan year, focusing on employers with employees in New York, New Jersey, Connecticut, and select other markets. The company plans to deploy capital to build technology and infrastructure, develop local partnerships, and support market launch.

Led · Series A · Sep 2023

Amenities Health provides a digital front door and patient loyalty platform that helps health systems acquire new patients, build brand loyalty, and grow revenue. Led by Dr. Aasim Saeed, Founder and CEO, the platform enables new patients to register and create a full EMR account instantly. The consumer-centric technology surfaces every available appointment across an entire health system network, including virtual and urgent care options, and organizes results by next available appointment, distance, and accepted insurance. The platform also delivers streamlined access to medical test results, provider messaging, and insurance billing information, integrated with common patient portals. Amenities plans to use the funding to accelerate adoption of its platform across health systems. Financially, the company closed a $6.25M tranche as part of its Series A, bringing total capital raised to $10M.